Association between routine biomarkers and atrial fibrillation in patients undergoing implantation of a dual‐chamber pacemaker

Kyrlas, Konstantinos; Liu, Tong; Bazoukis, George; Plakoutsi, S; Liberopoulos, Evangelos; Milionis, Haralampos; Korantzopoulos, Panagiotis

doi:10.1002/joa3.12479

Cited by 2 publications

(1 citation statement)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…On the other hand, there are data on changes in various biomarkers, which were also associated with an increased risk of tachyarrhythmia in PPM patients. In a study of adult PPM patients on the occasion of CVS, it was found that increased values of red blood cell distribution width (RDW) and γ-glutamyl transferase (γGT) in the serum were associated with an increased risk of AF [26].…”

Section: Introductionmentioning

confidence: 99%

Changes in hemodynamic parameters and atrial fibrillation risk in patients after permanent pacemaker implantation

Denislav Emilov Biserov

2024

World J. Adv. Res. Rev.

View full text Add to dashboard Cite

Data on the development of left ventricular dysfunction after permanent pacemaker implantation are available. According to data from the DAVID (The Dual Chamber and VVI Implantable Defibrillator) study, it was shown that DDDR-paced patients had significantly more fatal events and HF deterioration cases requiring hospitalization. Similar were the results of the MOde Selection Trial (MOST), which poses serious questions to the cardiology community. For that reason it is important to understand how PPM implantation changes the hemodynamic parameters of the heart and what consequences this may have. On the one hand, asynchronous contraction of the paced heart and increase in AF risk with advancing age require active screening of asymptomatic paroxysms of tachyarrhythmias to promptly adjust therapy. On the other hand, minimizing the rate of ventricular pacing through proper programming of the devices should not be overlooked. Recently, various biomarkers have been validated to select high-risk patients in which the therapeutic strategy can be modulated on time.

show abstract

Section: Introductionmentioning

confidence: 99%

Changes in hemodynamic parameters and atrial fibrillation risk in patients after permanent pacemaker implantation

Denislav Emilov Biserov

2024

World J. Adv. Res. Rev.

View full text Add to dashboard Cite

show abstract

Red Blood Cell Distribution Width is a Biomarker of Red Cell Dysfunction Associated with High Systemic Inflammation and a Prognostic Marker in Heart Failure and Cardiovascular Disease: A Potential Predictor of Atrial Fibrillation Recurrence

García-Escobar,

Lázaro-García,

Goicolea-Ruigómez

et al. 2024

High Blood Press Cardiovasc Prev

View full text Add to dashboard Cite

Association between routine biomarkers and atrial fibrillation in patients undergoing implantation of a dual‐chamber pacemaker

Abstract: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Cited by 2 publications

References 29 publications

Changes in hemodynamic parameters and atrial fibrillation risk in patients after permanent pacemaker implantation

Changes in hemodynamic parameters and atrial fibrillation risk in patients after permanent pacemaker implantation

Red Blood Cell Distribution Width is a Biomarker of Red Cell Dysfunction Associated with High Systemic Inflammation and a Prognostic Marker in Heart Failure and Cardiovascular Disease: A Potential Predictor of Atrial Fibrillation Recurrence

Contact Info

Product

Resources

About